Pinkerton Retirement Specialists »

Halozyme Therapeutics shares owned by Pinkerton Retirement Specialists

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Pinkerton Retirement Specialists from 13F filings

Historical chart of Pinkerton Retirement Specialists investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Pinkerton Retirement Specialists consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Pinkerton Retirement Specialists

Quarter filed Position value Share count Share price at filing
2024-09-30 $598k 10k 57.24

More positions owned by Pinkerton Retirement Specialists

Spdr S&p 500 Etf Trust Tr Unit (SPY)
Schwab U.s. Large-cap Etf Us Lrg Cap Etf (SCHX)
Ishares S&p 500 Growth Etf S&p 500 Grwt Etf (IVW)
Invesco Qqq Trust Series I Unit Ser 1 (QQQ)
Vanguard Intermediate-term Bond Etf Intermed Term (BIV)
Schwab International Equity Etf Intl Eqty Etf (SCHF)
Ishares U.s. Real Estate Etf U.s. Real Es Etf (IYR)
Ishares Msci Eafe Etf Msci Eafe Etf (EFA)
Ishares S&p Mid-cap 400 Growth Etf S&p Mc 400gr Etf (IJK)
Ishares S&p Small-cap 600 Growth Etf S&P SML 600 GWT (IJT)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
Schwab U.s. Broad Market Etf Us Brd Mkt Etf (SCHB)
Schwab Us Dividend Equity Etf Us Dividend Eq (SCHD)
Spdr Portfolio S&p 400 Mid Cap Etf Portfolio S&p400 (SPMD)
Spdr Gold Shares Gold Shs (GLD)

View all positions for Pinkerton Retirement Specialists

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Goldman Sachs Group
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics